Search Result "Teriflunomide"
DFT Study of Interaction between Teriflunomide and β-cyclodextrin
Journal: Current Molecular Medicine
Volume: 24 Issue: 0 Year: 2024 Page: 1-15
Author(s):
From Leflunomide to Teriflunomide: Drug Development and Immunosuppressive Oral Drugs in the Treatment of Multiple Sclerosis
Journal: Current Neuropharmacology
Volume: 15 Issue: 6 Year: 2017 Page: 874-891
Author(s): Lilian Aly,Bernhard Hemmer,Thomas Korn
Development of Validated Stability Indicating HPTLC Method for the Estimation of Teriflunomide in Bulk and Tablet Dosage Form
Journal: Current Pharmaceutical Analysis
Volume: 16 Issue: 7 Year: 2020 Page: 814-822
Author(s): Snehal Karmankar,M. Tajne
Comparison of Two Molecular Scaffolds, 5-Methylisoxazole-3-Carboxamide and 5-Methylisoxazole-4-Carboxamide
Journal: Current Pharmaceutical Design
Volume: 20 Issue: 1 Year: 2014 Page: 146-152
Author(s): Yaoming Song,Yiguan Zhang,An-Rong Lee,Wen-Hsin Huang,Ben Chen,Bruce Palfey,Jiajiu Shaw
Immune Therapy of Multiple Sclerosis - Future Strategies
Journal: Current Pharmaceutical Design
Volume: 18 Issue: 29 Year: 2012 Page: 4489-4497
Author(s): Sven G. Meuth,Kerstin Gobel,Heinz Wiendl
Current and Future Therapies Targeting the Immune System in Multiple Sclerosis
Journal: Current Pharmaceutical Biotechnology
Volume: 15 Issue: 3 Year: 2014 Page: 276-296
Author(s): Verena Loleit,Viola Biberacher,Bernhard Hemmer
Oral Agents in Multiple Sclerosis
Journal: Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry
Volume: 14 Issue: 1 Year: 2015 Page: 15-25
Author(s): L. Lorefice,G. Fenu,J. Frau,G.C. Coghe,M.G. Marrosu,E. Cocco
Etiopathogenesis, Classical Immunotherapy and Innovative Nanotherapeutics for Inflammatory Neurological Disorders
Journal: Current Nanoscience
Volume: 7 Issue: 1 Year: 2011 Page: 2-20
Author(s): Maria Jose Sa, Joana Guimaraes, Pedro Abreu, Amelia Mendes, Eliana B. Souto
Effect of the Intramolecular Hydrogen Bond on the Active Metabolite Analogs of Leflunomide for Blocking the Plasmodium falciparum Dihydroorotate Dehydrogenase Enzyme: QTAIM, NBO, and Docking Study
Journal: Current Computer-Aided Drug Design
Volume: 17 Issue: 3 Year: 2021 Page: 480-491
Author(s): Reihaneh Heidarian,Mansoureh Zahedi-Tabrizi
Leflunomide, a Reversible Monoamine Oxidase Inhibitor
Journal: Central Nervous System Agents in Medicinal Chemistry
Volume: 16 Issue: 2 Year: 2016 Page: 112-119
Author(s): Jacobus P. Petzer,Anél Petzer